Epidemiology and Antibiotic Susceptibility Patterns of Carbapenem Resistant Gram Negative Bacteria Isolated from Two Tertiary Care Hospitals in North Lebanon
Carbapenem Resistant Gram Negative Bacteria in North Lebanon
Keywords:Antibiotic Resistance, Carbapenem-Resistant bacteria, Epidemiology, Antibiotic Susceptibility Patterns, Tertiary care hospitals, Lebanon
Background. Antimicrobial resistance is a major public health problem worldwide. Numerous epidemiological studies reported that Lebanon is affected with high levels of antibiotic resistance. The aim of this study is to determine the prevalence and antibiotic susceptibility patterns of carbapenem resistant Gram negative bacteria in North Lebanon during the period 2015-2017.
Methods. Carbapenem resistant Gram negative bacteria were isolated from patients referring to Nini hospital and Youssef hospital center. Identification and antibiotic susceptibility testing were performed through conventional tools according to the manufacturerâ€™s recommended procedures and the recommendations of the European Committee on Antimicrobial Susceptibility Testing, respectively.
Results. Overall, a total of 290 carbapenem resistant Gram negative bacteria were isolated. Escherichia coli was predominant and represented 39.3% of all isolates, followed by Pseudomonas aeruginosa (24.8%), Acinetobacter baumannii (22.8%), Klebsiella spp. (8.6%), Enterobacter spp. (6.6%), Pantoea spp. (1%), and Proteus vulgaris (0.3%). Our findings showed an alarming increase in the prevalence of carbapenem resistant bacteria every year. On the other hand, colistin, tigecycline, amikacin and fosfomycin remain the most effective agents against carbapenem resistant Gram negative bacteria.
Conclusion. This study provided important new laboratory data that could support specialists in infectious diseases in North Lebanon to take the appropriate decision in the treatment of patients at risk for infections with carbapenem resistant Gram negative germs.
de Kraker ME, Stewardson AJ, Harbarth S. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS medicine. 2016;13(11):e1002184. doi: 10.1371/journal.pmed.1002184.
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial resistance and infection control. 2017;6:47. doi: 10.1186/s13756-017-0208-x.
Sonnevend A, Ghazawi A, Hashmey R, Haidermota A, Girgis S, Alfaresi M, et al. Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an ISEcp1-Directed blaOXA-181 Insertion in the mgrB Gene in the United Arab Emirates. Antimicrob Agents Chemother. 2017;61(7). doi: 10.1128/AAC.00418-17.
Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):15-21. doi: 10.1177/2049936115621709.
Al Bayssari C, Diene SM, Loucif L, Gupta SK, Dabboussi F, Mallat H, et al. Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon. Antimicrob Agents Chemother. 2014;58(8):4966-70. Epub 2014/06/11. doi: 10.1128/AAC.02523-13
Beyrouthy R, Robin F, Cougnoux A, Dalmasso G, Darfeuille-Michaud A, Mallat H, et al. Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli. J Antimicrob Chemother. 2013;68(7):1558-61. Epub 2013/03/01. doi: 10.1093/jac/dkt051
Beyrouthy R, Robin F, Dabboussi F, Mallat H, Hamze M, Bonnet R. Carbapenemase and virulence factors of Enterobacteriaceae in North Lebanon between 2008 and 2012: evolution via endemic spread of OXA-48. J Antimicrob Chemother. 2014;69(10):2699-705. doi: 10.1093/jac/dku181.
Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64-70. doi: 10.1016/j.ijid.2016.03.010.
Diab M, Hamze M, Madec JY, Haenni M. High Prevalence of Non-ST131 CTX-M-15-Producing Escherichia coli in Healthy Cattle in Lebanon. Microb Drug Resist. 2017;23(2):261-6. doi: 10.1089/mdr.2016.0019.
Hamze M, Mallat H, Dabbousi F, Achkar M. Antibiotic susceptibility and serotyping of clinical strains of Pseudomonas aeruginosa isolated in northern Lebanon. The International Arabic Journal of Antimicrobial Agents. 2012;2(4:2):1-6. doi: 10.3823/720.
Hamze M, Osman M, Mallat H, Achkar M. Antibiotic Susceptibility of Salmonella spp., Shigella spp. and enteropathogenic Escherichia coli strains isolated from diarrheic children in Tripoli, North Lebanon. International Arab Journal of Antimicrobial Resistance. 2016;6(2:2). doi: 10.3823/787.
Hamze M, Osman M, Mallat H, Achkar M. Prevalence and antibiotic susceptibility of ear pathogens isolated from patients in Tripoli, north of Lebanon. International Arab Journal of Antimicrobial Resistance. 2017;7(1:1). doi: 10.3823/0801.
Jamal S, Atrouni AA, Rafei R, Dabboussi F, Hamze M, Osman M. Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii with a special focus on its epidemiology in Lebanon. Journal of global antimicrobial resistance. 2018. doi: 10.1016/j.jgar.2018.05.022.
Osman M, Mallat H, Hamze M, Achkar M. Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North Lebanon. International Arab Journal of Antimicrobial Resistance. 2017;7(1:2). doi: 10.3823/0802.
Tabbouche S, Al Khudary R, Beyrouthy R, Dabbousi F, Achkar M, Mallat H, et al. Detection of genes TEM, OXA, SHV and CTX-M in 73 clinical isolates of Escherichia coli producers of extended spectrum beta-lactamases and determination of their susceptibility to antibiotics. International Arab Journal for Antimicrobial Agents. 2011;1:1-6.
Al Bayssari C, Olaitan AO, Dabboussi F, Hamze M, Rolain JM. Emergence of OXA-48-producing Escherichia coli clone ST38 in fowl. Antimicrob Agents Chemother. 2015;59(1):745-6. Epub 2014/10/29. doi: 10.1128/AAC.03552-14
Al-Bayssari C, Olaitan AO, Leangapichart T, Okdah L, Dabboussi F, Hamze M, et al. Whole-Genome Sequence of a blaOXA-48-Harboring Raoultella ornithinolytica Clinical Isolate from Lebanon. Antimicrob Agents Chemother. 2016;60(4):2548-50. doi: 10.1128/AAC.02773-15.
Amrieh S, Hamze M, Mallat H, Achkar M, Dabboussi F. Detection of Escherichia coli O157:H7 and O104:H4 in patients with diarrhea in Northern Lebanon and characterization of fecal E. coli producing ESBL and carbapenemase genes. The International Arabic Journal of Antimicrobial Agents. 2014;4(3:4). doi: 10.3823/756.
Rafei R, Dabboussi F, Hamze M, Eveillard M, Lemarie C, Mallat H, et al. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int J Infect Dis. 2014;21:21-3. doi: 10.1016/j.ijid.2014.01.004
Rafei R, Pailhories H, Hamze M, Eveillard M, Mallat H, Dabboussi F, et al. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla OXA-51-like sequence based typing. BMC Microbiol. 2015;15(1):103.
Salloum T, Tannous E, Alousi S, Arabaghian H, Rafei R, Hamze M, et al. Genomic Mapping of ST85 blaNDM-1 and blaOXA-94 producing Acinetobacter baumannii Isolates from Syrian Civil War Victims. Int J Infect Dis. 2018. doi: 10.1016/j.ijid.2018.07.017.
Menendez R, Mendez R, Polverino E, Rosales-Mayor E, Amara-Elori I, Reyes S, et al. Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations. BMC Infect Dis. 2017;17(1):659. doi: 10.1186/s12879-017-2754-5.
Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369-78. doi: 10.1016/j.jiph.2016.08.007.
Al Omari S, Al Mir H, Wrayde S, Merhabi S, Dhaybi I, Jamal S, et al. First Antibiotic Awareness Week Nationwide Initiative in Lebanon: Knowledge, Attitude and Practice towards Antibiotics. J Hosp Infect. 2018. doi: 10.1016/j.jhin.2018.07.009.
Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;15(10):1351-70. doi: 10.1517/14656566.2014.914172.
Vasoo S. Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward? J Clin Microbiol. 2017;55(9):2573-82. doi: 10.1128/JCM.00888-17.
Christophy R, Osman M, Mallat H, Achkar M, Ziedeh A, Moukaddem W, et al. Prevalence, antibiotic susceptibility and characterization of antibiotic resistant genes among carbapenem-resistant Gram-negative bacilli and yeast in intestinal flora of cancer patients in North Lebanon. J Infect Public Health. 2017;10(6):716-20. doi: 10.1016/j.jiph.2016.10.009.
Pontikis K, Karaiskos I, Bastani S, Dimopoulos G, Kalogirou M, Katsiari M, et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents. 2014;43(1):52-9. doi: 10.1016/j.ijantimicag.2013.09.010.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License Â©
Copyright policies & self-archiving
|Author's Pre-print:||author can archive pre-print (ie pre-refereeing)|
|Author's Post-print:||author can archive post-print (ie final draft post-refereeing)|
|Publisher's Version/PDF:||author can archive publisher's version/PDF|